𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides

✍ Scribed by Pei-Zhen Tao; Bengt Löfgren; Desmond Lake-Bakaar; Nils Gunnar Johansson; Roelf Datema; Professor Bo Öberg

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
605 KB
Volume
26
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Replication of hepadnaviruses involves a viral DNA polymerase containing both a DNA-dependent and an RNA dependent activity. This polymerase is a potential target for chemotherapy against hepatitis B. We have used human hepatitis B virus DNA-dependent DNA polymerase from human serum and duck hepatitis B virus DNA-dependent DNA polymerase from duck serum as well as RNA-dependent DNA polymerase activity from duck hepatitis B-infected duck liver. Triphosphates of thymidine analogs have been synthesized and tested for their inhibitory activities against these enzymes with the intention both to explore differences between these enzymes and structural requirements for inhibitors. The results showed that with the inhibitors tested, hepatitis B virus DNA-dependent DNA polymerase was the most sensitive enzyme and the triphosphate of 5-propenyl-2'-deoxyuridine was the most active inhibitor. In addition, the 5'-triphosphate of 5-propenyl-arabinofuranosyluracil also inhibited the hepadnavirus DNA-dependent DNA polymerases, and was a competitive inhibitor with respect to 2'-deoxythymidine triphosphate as showed by kinetic studies with duck hepatitis B virus DNA-dependent DNA polymerase from serum. Pharmacokinetic analysis showed 5-propenyl-2'-deoxyuridine to be well absorbed orally, but rapidly cleared from plasma. The arabinofuranosyl analog was also well absorbed but cleared less rapidly. Hence, these results indicate the potential of 5-propenyl-2'-deoxyuridine and 5-propenyl-arabinofuransyluracil for chemotherapy of hepatitis B.

📜 SIMILAR VOLUMES

Inhibition of hepatitis B virus DNA poly
Inhibition of hepatitis B virus DNA polymerase by 3′-fluorothymidine triphosphate and other modified nucleoside triphosphate analogs
✍ H. Meisel; K. Reimer; M. V. Janta-Lipinski; D. Bärwolff; E. Matthes 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

## Abstract The 3′‐fluoromodified nucleotide analogs 3′‐fluorothymidine triphosphate (FdTTP), 2′,3′‐dideoxy‐3′‐fluoro‐5‐chlorouridine triphosphate (F‐5CldUTP), 2′,3′‐dideoxy‐3′‐fluoro‐5‐ethyluridine triphosphate (F‐5EtdUTP), 2′,3′‐dideoxy‐3′‐fluorouridine triphosphate (FdUTP), and 2′,3′‐dideoxy‐3′‐

Inhibition of hepatitis B virus DNA poly
Inhibition of hepatitis B virus DNA polymerase by 3′-azido-3′-deoxythymidine triphosphate but not by its threo analog
✍ E. Nordenfelt; Bengt Löfgren; Jyoti Chattopadhyaya; Bo Öberg 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 2 views

An inhibitory effect of 3'-azido-3'-deoxythymidine triphosphate on hepatitis B virus DNA polymerase was found. No effect was seen by its threo analog. The effect was detected at and above a concentration of 0.05 microM. The inhibition of DNA polymerase activity was the same in ten different strains

Inactivation of human hepatitis b virus
Inactivation of human hepatitis b virus dna polymerase by pyridoxal 5′-phosphate
✍ Sang-Hwan Oh; Yeon-Hee Park; Koo Woo 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

Human hepatitis B virus (HBV) DNA polymerase activity was inhibited by pyridoxal 5'-phosphate (PLP) specifically and noncompetitively with respect to deoxythymidine triphosphate (dTTP). NaBH, reduction of PLP-HBV core proteins resulted in the complete inactivation of HBV DNA polymerase, and PLP modi

Properties of soluble dna polymerase fro
Properties of soluble dna polymerase from sera of hepatitis b virus carriers
✍ James C. H. Mao; Ellen R. Otis; Isa K. Mushahwar; Lacy R. Overby 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

## Abstract A soluble DNA polymerase was purified 8,000‐fold from hepatitis B surface antigen positive serum. The molecular weight of the enzyme by gel filtration was about 1.60 × 10^5^, the sedimentation coefficient was 5.5S, the apparent Km for dTTP was 4 MM, the optimum pH in the presence of Mg^

Inhibition of hepatitis B virus DNA poly
Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir
✍ T Shaw; S S Mok; S A Locarnini 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

The deoxyguanosine analog penciclovir (PCV; 9-[4-hydroxy-3-hydroxymethyl-but-1-yl]guanine), has shown potent antiviral activity against herpes viruses and hepadnaviruses. Efficacy against chronic hepatitis B virus (HBV) infection has been demonstrated in an animal model and in recent clinical trials